Apparent Mineralocorticoid Excess : report of Six New Cases and Extensive Personal Experience

G. Morineau, V. Sulmont, R. Salomon, B. Fiquet-Kempf, X. Jeunemaitre, J. Nicod, Paolo Ferrari

    Research output: Contribution to journalArticle

    62 Citations (Scopus)

    Abstract

    In mineralocorticoid target tissues such as the cortical collecting duct in the kidney, the enzyme 11β-hydroxysteroid dehydrogenase type 2 (11βHSD2) is responsible for the peripheral inactivation of cortisol to cortisone, thereby protecting the mineralocorticoid receptor from inappropriate activation by cortisol. Mutations in the HSD11B2 gene cause the syndrome of apparent mineralocorticoid excess, an autosomal recessive form of inherited hypertension in which cortisol acts as a potent mineralocorticoid. Herein are described six new families with mutations in the HSD11B2 gene causing hypokalemic hypertension, with low plasma aldosterone and low renin levels in affected individuals, indicating mineralocorticoid hypertension. Profiling of urinary steroid metabolites showed decreased cortisol inactivation, with urinary tetrahydrocortisol and tetrahydrocortisone ratio (THF + 5αTHF)/THE ranging 2.4 to 40 and nearly absent urinary free cortisone in all but one case. Genetic analysis of the HSD11B2 gene from these patients with apparent mineralocorticoid excess revealed distinct homozygous point mutations in four families, a compound heterozygous mutation in one family, and a large 23-bp exonic insert with frameshift and disruption of the amino acid sequence in another family. Expression studies of mutants that were expressed in HEK-293 cells showed marked reduction or abolition of 11βHSD2 enzymatic activity. These cases are reviewed along with previous ones from the authors’ extensive personal experience to highlight the importance of 11βHSD2 in the understanding of a new biologic principle in hormone action, demonstrating that local metabolism of the glucocorticoid hormones into inactive derivatives by the enzyme 11βHSD2 is one of the mechanisms that intervene to allow specific aldosterone regulatory effects.
    Original languageEnglish
    Pages (from-to)3176-3184
    JournalJournal of the American Society of Nephrology
    Volume17
    Issue number11
    DOIs
    Publication statusPublished - 2006

    Fingerprint Dive into the research topics of 'Apparent Mineralocorticoid Excess : report of Six New Cases and Extensive Personal Experience'. Together they form a unique fingerprint.

    Cite this